InnoVec Biotherapeutics Inc.
2 clinical trials · Sponsor
◉ Watch InnoVec Biotherapeutics Inc.
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy Study of IVB103 Injection in Subjects With Neovascular (Wet) Agerelated Macular Degeneration (nAMD). (NCT06737354) | InnoVec Biotherapeutics Inc. | 2025-04-22 |
| Safety and Efficacy Study of IVB102 Injection in Subjects With X-linked Retinoschisis (NCT06289452) | InnoVec Biotherapeutics Inc. | 2024-03-08 |
Track InnoVec Biotherapeutics Inc. automatically
Every clearance here is in the API, with alerts when new ones post.